Emrelis (telisotuzumab vedotin-tllv) has been granted accelerated approval by the US Food and Drug Administration (FDA), said ...

London-based specialty pharmaceutical company CNX Therapeutics is set to fast-track its European growth strategy after being ...

Swedish biotech firm PeptiSystems has joined forces with Asahi Kasei Bioprocess America in a global partnership set to ...

German pharmaceutical company Boehringer Ingelheim has entered a multi-year collaboration with Tempus AI (Nasdaq: TEM), ...

US Department of Health and Human Services (HHS) Secretary Robert F Kennedy Jr (RFK Jr) has spoken in defence of his proposed ...

Aiming to expand its hepatology portfolio, UK pharma major GSK (LSE: GSK) yesterday announced that it has entered into an ...

German science and technology company Merck (MRK: DE) reported a solid start to 2025, with group net sales rising 2.5% ...

Marking the latest move to pledge to spend billions of dollars into the USA, French pharm major Sanofi (Euronext: SAN) ...

Danish dermatology specialist LEO Pharma today released financial results for the first-quarter of 2025, noting its continued ...

Japanese pharma major Takeda (TYO: 4502) announced that the US Food and Drug Administration (FDA) has accepted for priority ...

Japanese drugmaker Chugai Pharmaceutical (TYO: 4519) has obtained regulatory approval from the domestic regulator for ...

The US Food and Drug Administration approved Welireg (belzutifan), from US pharma giant Merck & Co (NYSE: MRK), for adult and ...